Morphine metabolism in the pregnant guinea pig and her pups

Biology of the Neonate

Volumn 76, Issue 6, 1999, Pages 362-373

  Smith, Sue Ann ^b   Woolsey, Jeffrey B ^a   Olsen, George D ^a,b  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Chronic morphine exposure; Developmental pharmacokinetics; Morphine pharmacokinetics; Morphine 3 glucuronide; Morphine 6 glucuronide

Indexed keywords

DIAMORPHINE; LIVER ENZYME; MORPHINE; MORPHINE 3 GLUCURONIDE; MORPHINE 6 GLUCURONIDE; OPIATE;

AGE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ABUSE; DRUG METABOLISM; ENZYME KINETICS; FEMALE; GUINEA PIG; NEWBORN; NONHUMAN; PREGNANCY; PRENATAL EXPOSURE; PRIORITY JOURNAL;

ANIMALS; FEMALE; GUINEA PIGS; KINETICS; MATERNAL-FETAL EXCHANGE; MORPHINE; MORPHINE DERIVATIVES; PREGNANCY;

ANIMALIA; CAVIA; CAVIA PORCELLUS; SUS SCROFA;

EID: 0032737599     PISSN: 00063126     EISSN: None     Source Type: Journal    
DOI: 10.1159/000014180     Document Type: Article

References (51)

1. Inturrisi CE, Max MB, Foley KM, Shin SU, Houde RW: The pharmacokinetics of heroin in patients with chronic pain. N Engl J Med 1984; 310:1213-1217.
2. Way EL, Adler TK: The pharmacologic implications of the fate of morphine and its surrogates. Pharmacol Rev 1960;12:383-445.
3. Olsen GD, Norris SR, Sommer KM, Grosso SM: Placental permeability for morphine-3-β-D-glucuronide in the guinea pig. Placenta 1989;10: 83-93.
4. Murphy LJ, Olsen GD: Diffusion of morphine-6-β-D-glucuronide into the neonatal guinea pig brain during drug-induced respiratory depression. J Pharmacol Exp Ther 1994; 271:118-124.
5. Murphy LJ, Olsen GD: A stereospecific microassay for the determination of morphine-6-β-D-glucuronide and other active morphine metabolites in the neonatal guinea pig. L Liquid Chromatogr 1993;16:2545-2561.
6. Gong QL, Hedner T, Hedner J, Björkman R, Nordberg G: Antinociceptive and ventilatory effects of the morphine metabolites: Morphine-6-glucuronide and morphine-3-glucuronide. Eur J Pharmacol 1991;193: 47-56.
7. Pasternak GW, Bodner RJ, Clark JA, Inturrisi CE: Morphine-6-glucuronide, a potent mu agonist. Life Sci 1987;41:2845-2849.
8. Murphy LJ, Olsen GD: Morphine-6-β-D-glucuronide respiratory pharmacodynamics in the neonatal guinea pig. J Pharmacol Exp Ther 1994; 268:110-116.
9. Cochin J, Haggart J, Woods LA, Seevers MH: Plasma levels, urinary and fecal excretion of morphine in non-tolerant and tolerant dogs. J Pharmacol Exp Ther 1954;111:74-83.
10. Mellett LB, Woods LA: The distribution and fate of morphine in the non-tolerant and tolerant monkey. J Pharmacol Exp Ther 1956;116:77-83.
11. Woods LA: Distribution and fate of morphine in non-tolerant and tolerant dogs and rats. J Pharmacol Exp Ther 1954;112:158-175.
12. Zauder HL: The effect of prolonged morphine administration on the in vivo and in vitro conjugation of morphine by rats. J Pharmacol Exp Ther 1952;104:11-19.
13. Siminoff R, Saunders PR: Concentration of free and conjugated morphine in brain and other tissues of tolerant and nontolerant rabbits. J Pharmacol Exp Ther 1958;124:252-254.
14. Fan-Havard P, Koshy Z, Bais RM, Smith C, Eng RHK: Effect of morphine or phenobarbital on teicoplanin elimination pharmacokinetics. J Antimicrob Chemother 1993; 32:101-108.
15. Takemori AE, Glowacki GA: Studies on glucuronide synthesis in rats chronically treated with morphine and phenol. Biochem Pharmacol 1962;11:867-870.
16. Deneau GA, Woods LA, Seevers MH: Determination of in vitro disappearance of added morphine effected by minced tissues of morphine-tolerant rats during withdrawal. Fed Proc 1953;12:315.
17. Way EL, Sung CY, Fujimoto JM: The effect of adrenalectomy on the development of tolerance to morphine and methadone. J Pharmacol Exp Ther 1954;110:51.
18. Choonara I, Lawrence A, Michalkiewicz A, Bowhay A, Ratcliffe J: Morphine metabolism in neonates and infants. Br J Clin Pharmacol 1992: 34:434-437.
19. Hartley R, Quinn M, Green M, Levene MI: Morphine glucuronidation in premature neonates. Br J Clin Pharmacol 1993;35:314-317.
20. Hartley R, Green M, Quinn MW. Rushforth JA, Levene MI: Development of morphine glucuronidation in premature neonates. Biol Neonate 1994;66:1-9.
21. Collins JJ, Geake J, Grier HE. Houck CS, Thaler HT, Weinstein HJ, Twum-Danso NY, Berde CB: Patient-controlled analgesia for mucositis pain in children: A three-period crossover study comparing morphine and hydromorphone. J Pediatr 1996;129:722-728.
22. Lundeberg S, Beck O, Olsson GL, Boreus LO: Rectal administration of morphine in children. Pharmacokinetic evaluation after a single dose. Acta Anaesthesiol Scand 1996;40: 445-451.
23. Davis LE, Hohimer AR, Giraud GD, Paul MS, Morton MJ: Vascular pressure-volume relationships in pregnant and estrogen-treated guinea pigs. Am J Physiol 1989;257: R1205-R1211.
24. Pacifici GM, Sawe J, Kager L, Rane A: Morphine glucuronidation in human fetal and adult liver. Eur J Clin Pharmacol 1982;22:553-558.
25. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Folin phenol reagent. J Biol Chem 1951;193:265-275.
26. Gerdin E, Salmonson T, Lindberg B, Rane A: Maternal kinetics of morphine during labour. J Perinat Med 1990;18:479-487.
27. Lötsch J, Stockmann A, Kobal G, Brune K, Waibel R, Schmidt N, Geisslinger G: Pharmacokinetics of morphine and its glucuronides after intravenous infusion of morphine and morphine-6-glucuronide in healthy volunteers. Clin Pharmacol Ther 1996;60:316-325.
28. Patwardhan RV, Johnson RF, Hoyumpa A, Sheehan JJ, Desmond PV, Wilkinson GR, Branch RA, Schenker S: Normal metabolism of morphine in cirrhosis. Gastroenterology 1981;81:1006-1011.
29. Stanski DR, Greenblatt DJ, Lowenstein E: Kinetics of intravenous and intramuscular morphine. Clin Pharmacol Ther 1978;24:52-59.
30. Brunk SF, Delle M: Morphine metabolism in man. Clin Pharmacol Ther 1974;16:51-57.
31. Osborne R, Joel S, Trew D, Slevin M: Morphine and metabolite behavior after different routes of morphine administration: Demonstration of the importance of the active metabolite morphine-6-glucuronide. Clin Pharmacol Ther 1990;47: 12-19.
32. Stanski DR, Greenblatt DJ, Lappas DG, Koch-Weser J, Lowenstein E: Kinetics of high-dose intravenous morphine in cardiac surgery patients. Clin Pharmacol Ther 1976; 19:752-756.
33. Sawe J, Dahlstrom B, Paalzow L, Rane A: Morphine kinetics in cancer patients. Clin Pharmacol Ther 1981;30:629-635.
34. Golub MS, Eisele JH, Anderson JH: Maternal-fetal distribution of morphine and alfentanil in near-term sheep and rhesus monkeys. Dev Pharmacol Ther 1986;9:12-22.
35. Gabrielsson JL, Paalzow LK: A physiological pharmacokinetic model of morphine disposition in the pregnant rat. J Pharmacokinet Biopharm 1983;11:147-163.
36. Lawrence AJ, Michalkiewicz A, Morley JS, MacKinnon K, Billington D: Differential inhibition of hepatic morphine UDP-glucuronosyl-transferases by metal ions. Biochem Pharmacol 1992;43:2335-2340.
37. Dechelotte P, Sabouraud A, Sandouk P, Hackbarth I, Schwenk M: Uptake, 3-and 6-glucuronidation of morphine in isolated cells from stomach, intestine, colon, and liver of the guinea pig. Drug Metab Dispos 1993;21:13-17.
38. Sachen DS, Das SK: Alterations of NADPH-generating and drug-metabolizing enzymes by feed restriction in male rats. J Nutr 1982;112: 2301-2306.
39. Hietanen E: Modification of hepatic drug metabolizing enzyme activities and their induction by dietary protein. Gen Pharmacol 1980;11:443-450.
40. Berg CL, Radominska A, Lester R, Gollan JL: Membrane translocation and regulation of uridine diphosphate-glucuronic acid uptake in rat liver microsomal vesicles. Gastroenterology 1995;108:183-192.
41. Coughtrie MWH, Ask B, Rane A, Burchell B, Hume R: The enantio-selective glucuronidation of morphine in rats and humans. Biochem Pharmacol 1989;38:3273-3280.
42. Coffman BL, Rios GR, King CD, Tephly TR: Human UGT2B7 catalyzes morphine glucuronidation. Drug Metab Dispos 1997;25:1-3.
43. Hartley R, Green M, Quinn M, Levene MI: Pharmacokinetics of morphine infusion in premature neonates. Arch Dis Child 1993;69:55-58.
44. Mikkelsen S, Feilberg VL, Christensen CB, Lundstrom KE: Morphine pharmacokinetics in premature and mature newborn infants. Acta Paediatr 1994;83:1025-1028.
45. Chay PCW, Duffy BJ, Walker JS: Pharmacokinetic-pharmacodynamic relationship of morphine in neonates. Clin Pharmacol Ther 1992;51:334-342.
46. Bhat R, Chari G, Gulati A, Aldana O, Velamati R, Bhargava H: Pharmacokinetics of a single dose of morphine in preterm infants during the first week of life. J Pediatr 1990; 117:477-481.
47. Lynn AM. Slattery JT: Morphine pharmacokinetics in early infancy. Anesthesiology 1987;66:136-139.
48. Pokela ML, Olkkola KT, Seppala T, Koivisto M: Age-related morphine kinetics in infants. Dev Pharmacol Ther 1993;20:26-34.
49. Dahlstrom B, Bolme P, Feychting H, Noack G, Paalzow L: Morphine kinetics in children. Clin Pharmacol Ther 1979;26:354-365.
50. Dampier CD, Setty NY, Logan J, Ioli JG, Dean R: Intravenous morphine pharmacokinetics in pediatric patients with sickle cell disease. J Pediatr 1995;126:461-467.
51. Lynn AM, McRorie TI, Slattery JT, Calkins D, Opheim KE: Pharmacokinetics and pharmacodynamics of morphine in infant monkeys. Dev Pharmacol Ther 1991;16:41-47.